The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies

The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies

P. aeruginosa is classified as a priority one pathogen by the World Health Organisation, and new drugs are urgently needed, due to the emergence of multidrug-resistant (MDR) strains. Antimicrobial-resistant nosocomial pathogens such as P. aeruginosa pose unwavering and increasing threats. Antimicrob...

Full description

Bibliographic Details
Main Authors:	R. Frèdi Langendonk, Daniel R. Neill, Joanne L. Fothergill
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	multidrug-resistance (MDR) resistance mechanism interplay antimicrobial resistance (AMR) resistance-breaking therapy adjuvant therapies Pseudomonas aeruginosa
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2021.665759/full

Similar Items

Genomic Surveillance of Clinical Pseudomonas aeruginosa Isolates Reveals an Additive Effect of Carbapenemase Production on Carbapenem Resistance
by: Luke Diorio-Toth, et al.
Published: (2022-06-01)

Antibiotic resistance profiles and associated factors of Pseudomonas Infections among patients admitted to large tertiary care hospital from a developing country
by: Sara Shbaita, et al.
Published: (2023-12-01)

Multidrug resistant Pseudomonas aeruginosa in Iran: A systematic review and metaanalysis
by: Hamid Vaez, et al.
Published: (2018-01-01)

Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant <em>Pseudomonas aeruginosa</em> Infections
by: Dana Holger, et al.
Published: (2021-05-01)

Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies
by: Ahmed Elfadadny, et al.
Published: (2024-04-01)

Case Report: Colistin Use in the Treatment of Multidrug Resistant Pseudomonas aeruginosa
by: Özge TURHAN, et al.
Published: (2001-06-01)

Identification and Characterization of New Bacteriophages to Control Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Endotracheal Tubes
by: Viviane C. Oliveira, et al.
Published: (2020-10-01)

Incidence of Multidrug Resistant Pseudomonas Aeruginosa Isolated from Burn Patients and Environment of Teaching Institution
by: Indu Biswal, et al.
Published: (2014-05-01)

Distribution of the Strains of Multidrug-resistant, Extensively Drug-resistant, and Pandrug-resistant Pseudomonas aeruginosa Isolates from Burn Patients
by: Hajieh Ghasemian Safaei, et al.
Published: (2017-01-01)

Antibiotic resistance of Pseudomonas aeruginosa isolated from hospital wastewater in the Czech Republic
by: Nikola Roulová, et al.
Published: (2022-04-01)

The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> in Clinical Settings
by: Frank Jones, et al.
Published: (2022-02-01)

Derivation of a score to predict infection due to multidrug-resistant Pseudomonas aeruginosa: a tool for guiding empirical antibiotic treatment
by: Pilar Hernández-Jiménez, et al.
Published: (2022-06-01)

Genotyping, Pandrug Resistance, Extensively Drug-Resistant, and Multi Drug-Resistance Detection of Pseudomonas aeruginosa Isolated From Patients in the West of Iran
by: Samaneh Rouhi, et al.
Published: (2019-04-01)

Dissemination of Class 1 Integron among Different Multidrug Resistant Pseudomonas aeruginosa Strains
by: Zahra Salimizadeh, et al.
Published: (2018-07-01)

The prevalence of Pseudomonas aeruginosa and multidrug resistant Pseudomonas aeruginosa in healthy captive ophidian
by: Andrea Sala, et al.
Published: (2019-04-01)

Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies
by: Alessia Catalano, et al.
Published: (2022-01-01)

Multidrug-resistant Pseudomonas aeruginosa in healthcare facilities in Port-au-Prince, Haiti
by: Kathrine McAulay, et al.
Published: (2021-06-01)

Prevalence and molecular analysis of antibiotic resistance of Pseudomonas aeruginosa isolated from clinical and environmental specimens in Basra, Iraq
by: Zeina MM Alkhulaifi, et al.
Published: (2023-02-01)

Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015
by: Maroya Spalding Walters, et al.
Published: (2019-07-01)

Gene regulatory network inference and analysis of multidrug-resistant Pseudomonas aeruginosa
by: Fernando Medeiros Filho, et al.

Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study
by: Hyo Sup Kim, et al.
Published: (2017-07-01)

The Versatile Mutational Resistome of Pseudomonas aeruginosa
by: Carla López-Causapé, et al.
Published: (2018-04-01)

Emergence of Multidrug-resistant Carbapenemases and MCR-1 Producing Pseudomonas aeruginosa in Egypt
by: Khaled M. Aboelsuod, et al.
Published: (2023-03-01)

Prevalence of multi-drug resistant <em>Pseudomonas aeruginosa</em> isolated from selected residential sewages in Dutsin-Ma, Katsina State, Nigeria
by: Ayodele Timilehin Adesoji, et al.
Published: (2023-03-01)

Extensively drug-resistant Pseudomonas aeruginosa panophthalmitis from contaminated artificial tears
by: Taylor Wang, et al.
Published: (2023-01-01)

Antimicrobial resistance of clinical bacterial isolates according to the WHO’s AWaRe and the ECDC-MDR classifications: the pattern in Ghana’s Bono East Region
by: Williams Walana, et al.
Published: (2023-12-01)

Prevalence of multidrug-resistant, extensively drug-resistant, and pandrug-resistant Pseudomonas aeruginosa from a tertiary level Intensive Care Unit
by: J S Gill, et al.
Published: (2016-01-01)

The Prevalence of Exoenzyme S Gene in Multidrug-Sensitive and Multidrug-Resistant Pseudomonas aeruginosa Clinical Strains
by: Tomasz Bogiel, et al.
Published: (2017-12-01)

Post-cataract surgery cluster endophthalmitis due to multidrug-resistant Pseudomonas aeruginosa: A retrospective cohort study of six clusters
by: Swapnil M Parchand, et al.
Published: (2020-01-01)

The novel potential multidrug-resistance biomarkers for Pseudomonas aeruginosa lung infections using transcriptomics data analysis
by: Nazanin Hosseinkhan, et al.
Published: (2021-01-01)

Prevalensi dan Pola Sensitivitas Antimikroba Multidrug Resistant Pseudomonas aeruginosa di RSUD Arifin Achmad
by: Dewi Anggraini, et al.
Published: (2018-03-01)

Pseudomonas aeruginosa: freqüência de resistência a múltiplos fármacos e resistência cruzada entre antimicrobianos no Recife/PE Pseudomonas aeruginosa: frequency of resistance to multiple drugs and cross-resistance between antimicrobials in Recife/PE
by: Eduardo Andrada Pessoa de Figueiredo, et al.
Published: (2007-12-01)

The draft genome sequence of multidrug-resistant Pseudomonas aeruginosa strain CCBH4851, a nosocomial isolate belonging to clone SP (ST277) that is prevalent in Brazil
by: Melise Silveira, et al.
Published: (2014-12-01)

Emergence of Multidrug-Resistant Pseudomonas aeruginosa: Detection of Isolates harboring blaCTX gene causing infections in hospital and determination of their susceptibility to antibiotics
by: Z Rabani, et al.
Published: (2015-11-01)

The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
by: Atqah AbdulWahab, et al.
Published: (2017-01-01)

Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in patients with hematological diseases
by: Sisi Zhen, et al.
Published: (2023-06-01)

Antibiotic resistance profiles and activity of clove essential oil (Syzygium aromaticum) against Pseudomonas aeruginosa isolated of canine otitis
by: Larissa Vieira Costa, et al.
Published: (2022-10-01)

Ceftolozane-tazobactam vs. colistin for the treatment of infections due to multidrug-resistant Pseudomonas aeruginosa: a multicentre cohort study
by: Thamer A. Almangour, et al.
Published: (2022-03-01)

Pseudomonas aeruginosa device associated – healthcare associated infections and its multidrug resistance at intensive care unit of University Hospital: polish, 8.5-year, prospective, single-centre study
by: Agnieszka Litwin, et al.
Published: (2021-02-01)

Multiple Mechanisms Synergistically Induce Pseudomonas Aeruginosa Multiple Drug Resistance
by: Pei Dai, et al.
Published: (2023-05-01)